LON:APH Alliance Pharma (APH) Share Price, News & Analysis GBX 64.70 0.00 (0.00%) As of 05/14/2025 Add Compare Share Share Stock Analysis Stock Analysis About Alliance Pharma Stock (LON:APH) Get Alliance Pharma alerts:Sign Up Key Stats Today's Range 64.70▼ 64.7050-Day Range 64.70▼ 64.7052-Week Range 30.50▼ 66.20VolumeN/AAverage Volume5.95 million shsMarket Capitalization£350.31 millionP/E RatioN/ADividend Yield3.75%Price TargetN/AConsensus RatingN/A Company Overview Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom. Read More Receive APH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APH Stock News HeadlinesRBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)March 11, 2025 | markets.businessinsider.comAlliance Pharma Valued at $468 Million Under Increased Offer From Aegros BidcoMarch 10, 2025 | marketwatch.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 6 at 1:00 AM | Behind the Markets (Ad)Alliance Pharma agrees £362m takeover by biggest shareholderMarch 10, 2025 | msn.comUK's Alliance Pharma agrees to final cash offer from asset management firm DBAYMarch 10, 2025 | reuters.comAlliance Pharma And 2 Other UK Penny Stocks With Promising FundamentalsFebruary 27, 2025 | finance.yahoo.comAlliance Pharma Expected Revenue Falls on Consumer Healthcare DeclineJanuary 31, 2025 | marketwatch.comAlliance Pharma Regulatory NewsJanuary 31, 2025 | lse.co.ukSee More Headlines APH Stock Analysis - Frequently Asked Questions How have APH shares performed this year? Alliance Pharma's stock was trading at GBX 64.70 at the start of the year. Since then, APH stock has increased by 0.0% and is now trading at GBX 64.70. How were Alliance Pharma's earnings last quarter? Alliance Pharma plc (LON:APH) issued its quarterly earnings data on Tuesday, April, 8th. The company reported GBX 4.32 EPS for the quarter. Alliance Pharma had a negative trailing twelve-month return on equity of 5.04% and a negative net margin of 6.00%. What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include Aviva (AV), BAE Systems (BA), Babcock International Group (BAB), boohoo group (BOO), BP (BP), Centrica (CNA) and The Gym Group (GYM). Company Calendar Last Earnings4/08/2025Today11/06/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolLON:APH CIKN/A Webwww.alliancepharma.co.uk Phone+44-1249-466966FaxN/AEmployees91,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (6.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.04Net Income-£33.65 million Net Margins-6.00% Pretax MarginN/A Return on Equity-5.04% Return on Assets5.98% Debt Debt-to-Equity Ratio46.09 Current Ratio2.84 Quick Ratio1.42 Sales & Book Value Annual Sales£183.50 million Price / Sales1.91 Cash FlowGBX 8.22 per share Price / Cash Flow7.87 Book ValueGBX 41.25 per share Price / Book1.57Miscellaneous Outstanding Shares541,444,969Free FloatN/AMarket Cap£350.31 million OptionableNot Optionable Beta0.67 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (LON:APH) was last updated on 5/14/2025 by MarketBeat.com Staff. From Our PartnersEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredTesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.Tesla has never paid shareholders a dividend, not one cent. A new fund built on Tesla's stock takes a differen...Investors Alley | SponsoredA little-known law has been quietly applied to your savings for years.Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution...Monetary Gold | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredYour first step can stay on paperIncome Blueprint, created by Matt, helps traders find and evaluate options opportunities. In his walkthrough, ...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alliance Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
